CTI BioPharma Statistics
Total Valuation
CACC has a market cap or net worth of $5.03 billion. The enterprise value is $11.43 billion.
| Market Cap | 5.03B |
| Enterprise Value | 11.43B |
Important Dates
The last earnings date was Thursday, July 31, 2025, after market close.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CACC has 11.24 million shares outstanding. The number of shares has decreased by -4.08% in one year.
| Current Share Class | 11.24M |
| Shares Outstanding | 11.24M |
| Shares Change (YoY) | -4.08% |
| Shares Change (QoQ) | -4.14% |
| Owned by Insiders (%) | 14.74% |
| Owned by Institutions (%) | 55.08% |
| Float | 6.19M |
Valuation Ratios
The trailing PE ratio is 12.88 and the forward PE ratio is 10.80.
| PE Ratio | 12.88 |
| Forward PE | 10.80 |
| PS Ratio | 4.60 |
| Forward PS | 2.08 |
| PB Ratio | 3.23 |
| P/TBV Ratio | 3.23 |
| P/FCF Ratio | 4.54 |
| P/OCF Ratio | 4.53 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.93 |
| EV / Sales | 9.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 10.32 |
Financial Position
The company has a current ratio of 21.84, with a Debt / Equity ratio of 4.16.
| Current Ratio | 21.84 |
| Quick Ratio | 20.58 |
| Debt / Equity | 4.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | 5.84 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 27.30%.
| Return on Equity (ROE) | 27.30% |
| Return on Assets (ROA) | 5.00% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $482,600 |
| Profits Per Employee | $174,578 |
| Employee Count | 2,431 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CACC has paid $133.50 million in taxes.
| Income Tax | 133.50M |
| Effective Tax Rate | 23.93% |
Stock Price Statistics
The stock price has decreased by -22.66% in the last 52 weeks. The beta is 1.14, so CACC's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -22.66% |
| 50-Day Moving Average | 503.78 |
| 200-Day Moving Average | 488.13 |
| Relative Strength Index (RSI) | 29.66 |
| Average Volume (20 Days) | 107,209 |
Short Selling Information
The latest short interest is 656,947, so 5.85% of the outstanding shares have been sold short.
| Short Interest | 656,947 |
| Short Previous Month | 689,788 |
| Short % of Shares Out | 5.85% |
| Short % of Float | 10.61% |
| Short Ratio (days to cover) | 3.39 |
Income Statement
In the last 12 months, CACC had revenue of $1.17 billion and earned $424.40 million in profits. Earnings per share was $34.75.
| Revenue | 1.17B |
| Gross Profit | 1.10B |
| Operating Income | 559.10M |
| Pretax Income | 244.00M |
| Net Income | 424.40M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $34.75 |
Balance Sheet
The company has $70.00 million in cash and $6.47 billion in debt, giving a net cash position of -$6.40 billion or -$569.62 per share.
| Cash & Cash Equivalents | 70.00M |
| Total Debt | 6.47B |
| Net Cash | -6.40B |
| Net Cash Per Share | -$569.62 |
| Equity (Book Value) | 1.55B |
| Book Value Per Share | 134.33 |
| Working Capital | 8.18B |
Cash Flow
In the last 12 months, operating cash flow was $1.11 billion and capital expenditures -$1.70 million, giving a free cash flow of $1.11 billion.
| Operating Cash Flow | 1.11B |
| Capital Expenditures | -1.70M |
| Free Cash Flow | 1.11B |
| FCF Per Share | $98.61 |
Margins
Gross margin is 93.85%, with operating and profit margins of 47.66% and 36.17%.
| Gross Margin | 93.85% |
| Operating Margin | 47.66% |
| Pretax Margin | 47.55% |
| Profit Margin | 36.17% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 94.45% |
Dividends & Yields
CACC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.08% |
| Shareholder Yield | 4.08% |
| Earnings Yield | 8.44% |
| FCF Yield | 22.03% |
Analyst Forecast
The average price target for CACC is $475.00, which is 6.83% higher than the current price. The consensus rating is "Sell".
| Price Target | $475.00 |
| Price Target Difference | 6.83% |
| Analyst Consensus | Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 1994. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 21, 1994 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |